Global Scientific Publications Lead, Dermatology

The Publications Lead, Dermatology will be responsible for the development and execution of the Global Publication Plan for Dupilumab in Dermatology (Atopic Dermatitis). This includes strategic planning, cross-functional partnership, and leadership in development of the plan as well as ensuring the compliant execution of tactics in accordance with global medical strategy, industry standards (ie. ICMJE, GPP), and Sanofi policies. This role will involve close collaboration with medical and cross-functional stakeholders, publications agencies, alliance partners, and global affiliates.

The ideal candidate will have publications management experience and a clear understanding of publication planning, operations, and industry guidelines. Candidates must possess the ability to direct multiple complex projects, direct agencies and medical writers, and ensure timelines and deliverables are maintained. In addition, candidates must adhere to policies and best practices in publication governance including internal and external reviews and approvals, compliance activities, reporting, and metrics.

This is an exciting opportunity to be part of a passionate, high profile, high-impact Medical Affairs Scientific Communications team, and to work in a highly dynamic and collaborative setting.

Domestic and international travel will be required (approx. 10%).

The position is based in Cambridge, MA, or remote (US-based).

Key Responsibilities

• Lead the development of the annual publication plan for Dupilumab in Atopic Dermatitis, including strategic and tactical planning, prioritization of scientific communications priorities, and budget

• Ensure the compliant execution of publications in accordance with approved medical strategy, industry guidelines, and established timelines

• Collaborate with Medical study leads, cross-functional partners, and affiliates to ensure synergistic tactical planning and execution of publication deliverables and associated outputs

• Lead and/or contribute to global publication planning team meetings, as well as other cross-functional or alliance meetings.

• Oversee publications agencies to manage operational logistics associated with project planning and execution

• Develop and maintain reasonable expertise in the dermatology therapeutic area and Dupilumab mechanism of action

• Participate in or lead training activities for internal stakeholders as required

• Participate in relevant cross-functional teams and task forces and give presentations to colleagues and senior management as required

Scope of Work

• Adult Atopic Dermatitis Phase 4 /extension studies and key prioritized manuscripts (i.e., 5 yr open label, hand and foot)

  • Encores and Adaptations are included in this scope but may be supported by another resource (i.e., agency or hub)

Key Qualifications

• Advanced scientific or clinical degree in the life sciences (e.g., Ph.D., Pharm.D., M.D.)

• At least 2 years’ experience in a publication management role or medical writing role, and/or 3-5 years’ experience in medical affairs, scientific communications, or related role

• Knowledge of industry guidelines pertaining to data dissemination (e.g., CONSORT, ICMJE, GPPs) and interactions with health care providers (e.g., PhRMA Code, AdvaMed guidelines)

• Experience and demonstrated skill in the analysis, communication and presentation of complex scientific and medical data

• Excellent interpersonal skills, negotiation skills, and verbal and written communication skills

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

As a healthcare company and a vaccine manufacturer, Sanofi has an important responsibility to protect individual and public health. All US based roles require individuals to be fully vaccinated against COVID-19 as part of your job responsibilities.

According to the CDC, an individual is considered to be “fully vaccinated” fourteen (14) days after receiving (a) the second dose of the Moderna or Pfizer vaccine, or (b) the single dose of the J&J vaccine. Fully vaccinated, for new Sanofi employees, is to be fully vaccinated 14 DAYS PRIOR TO START DATE.

#GD-SG 
#LI-GZ

At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.